Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern Chinese and western medicine in China. Th...
The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit
A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit
WECOME Pharmaceuticals released its performance for the first three quarters, with a net loss attributable to the parent company of 124 million yuan
The A-share chain pharmacy IPO project is here: Kangbaijia starts counseling
The Zhejiang Securities Regulatory Bureau has issued warning letters to Minsheng Securities, Ren Shaozhong, and Zhong Desong
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up